Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Performance of the TB-LAMP diagnostic assay in reference laboratories: Results from a multicentre study.

Pham TH, Peter J, Mello FCQ, Parraga T, Lan NTN, Nabeta P, Valli E, Caceres T, Dheda K, Dorman SE, Hillemann D, Gray CM, Perkins MD.

Int J Infect Dis. 2018 Mar;68:44-49. doi: 10.1016/j.ijid.2018.01.005. Epub 2018 Feb 2.

2.

Serologic Responses in Childhood Pulmonary Tuberculosis.

Nonyane BAS, Nicol MP, Andreas NJ, Rimmele S, Schneiderhan-Marra N, Workman LJ, Perkins MD, Joos T, Broger T, Ellner JJ, Alland D, Kampmann B, Dorman SE, Zar HJ.

Pediatr Infect Dis J. 2018 Jan;37(1):1-9. doi: 10.1097/INF.0000000000001683.

3.

Diagnostic preparedness for infectious disease outbreaks.

Perkins MD, Dye C, Balasegaram M, Bréchot C, Mombouli JV, Røttingen JA, Tanner M, Boehme CC.

Lancet. 2017 Nov 11;390(10108):2211-2214. doi: 10.1016/S0140-6736(17)31224-2. Epub 2017 May 31.

PMID:
28577861
4.

Diagnostic Performance of Tuberculosis-Specific IgG Antibody Profiles in Patients with Presumptive Tuberculosis from Two Continents.

Broger T, Basu Roy R, Filomena A, Greef CH, Rimmele S, Havumaki J, Danks D, Schneiderhan-Marra N, Gray CM, Singh M, Rosenkrands I, Andersen P, Husar GM, Joos TO, Gennaro ML, Lochhead MJ, Denkinger CM, Perkins MD.

Clin Infect Dis. 2017 Apr 1;64(7):947-955. doi: 10.1093/cid/cix023.

5.

Market assessment of tuberculosis diagnostics in India in 2013.

Maheshwari P, Chauhan K, Kadam R, Pujani A, Kaur M, Chitalia M, Dabas H, Perkins MD, Boehme CC, Denkinger CM, Raizada N, Ginnard J, Jefferson C, Pantoja A, Rupert S, Kik SV, Cohen C, Chedore P, Satyanarayana S, Pai M; TB Diagnostics Market Analysis Consortium.

Int J Tuberc Lung Dis. 2016 Mar;20(3):304-13. doi: 10.5588/ijtld.15.0571.

PMID:
27046709
6.

Market assessment of tuberculosis diagnostics in China in 2012.

Zhao YL, Pang Y, Xia H, Du X, Chin D, Huan ST, Dong HY, Zhang ZY, Ginnard J, Perkins MD, Boehme CC, Jefferson C, Pantoja A, Qin ZZ, Chedore P, Denkinger CM, Pai M, Kik SV; TB Diagnostics Market Analysis Consortium.

Int J Tuberc Lung Dis. 2016 Mar;20(3):295-303. doi: 10.5588/ijtld.15.0156.

PMID:
27046708
7.

Estimation of D-Arabinose by Gas Chromatography/Mass Spectrometry as Surrogate for Mycobacterial Lipoarabinomannan in Human Urine.

De P, Amin AG, Valli E, Perkins MD, McNeil M, Chatterjee D.

PLoS One. 2015 Dec 3;10(12):e0144088. doi: 10.1371/journal.pone.0144088. eCollection 2015.

8.

United States FDA's emergency use authorization of Ebola virus diagnostics: current impact and lessons for the future.

Whitehouse CA, Bavari S, Perkins MD.

Expert Rev Mol Diagn. 2015;15(10):1231-5. doi: 10.1586/14737159.2015.1077117. Epub 2015 Sep 7.

PMID:
26394699
9.

Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3.

Zeng L, Wang B, Merillat SA, Minakawa EN, Perkins MD, Ramani B, Tallaksen-Greene SJ, Costa MDC, Albin RL, Paulson HL.

Neurobiol Dis. 2015 Oct;82:281-288. doi: 10.1016/j.nbd.2015.06.017. Epub 2015 Jun 30.

10.

ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study.

Broadhurst MJ, Kelly JD, Miller A, Semper A, Bailey D, Groppelli E, Simpson A, Brooks T, Hula S, Nyoni W, Sankoh AB, Kanu S, Jalloh A, Ton Q, Sarchet N, George P, Perkins MD, Wonderly B, Murray M, Pollock NR.

Lancet. 2015 Aug 29;386(9996):867-74. doi: 10.1016/S0140-6736(15)61042-X. Epub 2015 Jun 25.

PMID:
26119838
11.

The Case for Improved Diagnostic Tools to Control Ebola Virus Disease in West Africa and How to Get There.

Chua AC, Cunningham J, Moussy F, Perkins MD, Formenty P.

PLoS Negl Trop Dis. 2015 Jun 11;9(6):e0003734. doi: 10.1371/journal.pntd.0003734. eCollection 2015 Jun. No abstract available.

12.

What Ebola tells us about outbreak diagnostic readiness.

Perkins MD, Kessel M.

Nat Biotechnol. 2015 May;33(5):464-9. doi: 10.1038/nbt.3215. No abstract available.

PMID:
25965752
13.

Integration of published information into a resistance-associated mutation database for Mycobacterium tuberculosis.

Salamon H, Yamaguchi KD, Cirillo DM, Miotto P, Schito M, Posey J, Starks AM, Niemann S, Alland D, Hanna D, Aviles E, Perkins MD, Dolinger DL.

J Infect Dis. 2015 Apr 1;211 Suppl 2:S50-7. doi: 10.1093/infdis/jiu816. Review.

14.

Target product profile of a molecular drug-susceptibility test for use in microscopy centers.

Denkinger CM, Dolinger D, Schito M, Wells W, Cobelens F, Pai M, Zignol M, Cirillo DM, Alland D, Casenghi M, Gallarda J, Boehme CC, Perkins MD.

J Infect Dis. 2015 Apr 1;211 Suppl 2:S39-49. doi: 10.1093/infdis/jiu682. Review.

15.

The design and evaluation of a shaped filter collection device to sample and store defined volume dried blood spots from finger pricks.

Polley SD, Bell D, Oliver J, Tully F, Perkins MD, Chiodini PL, González IJ.

Malar J. 2015 Feb 5;14:45. doi: 10.1186/s12936-015-0558-x.

16.

Characterization of the physical stability of a lyophilized IgG1 mAb after accelerated shipping-like stress.

Telikepalli S, Kumru OS, Kim JH, Joshi SB, O'Berry KB, Blake-Haskins AW, Perkins MD, Middaugh CR, Volkin DB.

J Pharm Sci. 2015 Feb;104(2):495-507. doi: 10.1002/jps.24242. Epub 2014 Dec 17.

17.

Operational implementation of LED fluorescence microscopy in screening tuberculosis suspects in an urban HIV clinic in Uganda.

Albert H, Nakiyingi L, Sempa J, Mbabazi O, Mukkada S, Nyesiga B, Perkins MD, Manabe YC.

PLoS One. 2013 Sep 6;8(9):e72556. doi: 10.1371/journal.pone.0072556. eCollection 2013.

18.

Highly sensitive detection of malaria parasitemia in a malaria-endemic setting: performance of a new loop-mediated isothermal amplification kit in a remote clinic in Uganda.

Hopkins H, González IJ, Polley SD, Angutoko P, Ategeka J, Asiimwe C, Agaba B, Kyabayinze DJ, Sutherland CJ, Perkins MD, Bell D.

J Infect Dis. 2013 Aug 15;208(4):645-52. doi: 10.1093/infdis/jit184. Epub 2013 Apr 30. Erratum in: J Infect Dis. 2014 May 1;209(9):1494.

19.

Clinical evaluation of a loop-mediated amplification kit for diagnosis of imported malaria.

Polley SD, González IJ, Mohamed D, Daly R, Bowers K, Watson J, Mewse E, Armstrong M, Gray C, Perkins MD, Bell D, Kanda H, Tomita N, Kubota Y, Mori Y, Chiodini PL, Sutherland CJ.

J Infect Dis. 2013 Aug 15;208(4):637-44. doi: 10.1093/infdis/jit183. Epub 2013 Apr 30.

20.

Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action.

Wells WA, Boehme CC, Cobelens FG, Daniels C, Dowdy D, Gardiner E, Gheuens J, Kim P, Kimerling ME, Kreiswirth B, Lienhardt C, Mdluli K, Pai M, Perkins MD, Peter T, Zignol M, Zumla A, Schito M.

Lancet Infect Dis. 2013 May;13(5):449-58. doi: 10.1016/S1473-3099(13)70025-2. Epub 2013 Mar 24. Review.

21.

Transforming TB diagnosis: can patients and control programs afford to wait?

Talbot EA, Pape JW, Sundaram L, Boehme CC, Perkins MD.

Am J Trop Med Hyg. 2012 Aug;87(2):202-4. doi: 10.4269/ajtmh.2012.12-0247. No abstract available.

22.

Proteome-scale antibody responses and outcome of Mycobacterium tuberculosis infection in nonhuman primates and in tuberculosis patients.

Kunnath-Velayudhan S, Davidow AL, Wang HY, Molina DM, Huynh VT, Salamon H, Pine R, Michel G, Perkins MD, Xiaowu L, Felgner PL, Flynn JL, Catanzaro A, Gennaro ML.

J Infect Dis. 2012 Sep 1;206(5):697-705. doi: 10.1093/infdis/jis421. Epub 2012 Jun 25.

23.

Clinical research and development of tuberculosis diagnostics: moving from silos to synergy.

Nahid P, Kim PS, Evans CA, Alland D, Barer M, Diefenbach J, Ellner J, Hafner R, Hamilton CD, Iademarco MF, Ireton G, Kimerling ME, Lienhardt C, MacKenzie WR, Murray M, Perkins MD, Posey JE, Roberts T, Sizemore C, Stevens WS, Via L, Williams SD, Yew WW, Swindells S.

J Infect Dis. 2012 May 15;205 Suppl 2:S159-68. doi: 10.1093/infdis/jis194. Epub 2012 Apr 3. Review.

24.

New developments in malaria diagnostics: monoclonal antibodies against Plasmodium dihydrofolate reductase-thymidylate synthase, heme detoxification protein and glutamate rich protein.

Kattenberg JH, Versteeg I, Migchelsen SJ, González IJ, Perkins MD, Mens PF, Schallig HD.

MAbs. 2012 Jan-Feb;4(1):120-6. doi: 10.4161/mabs.4.1.18529.

25.

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis.

Vassall A, van Kampen S, Sohn H, Michael JS, John KR, den Boon S, Davis JL, Whitelaw A, Nicol MP, Gler MT, Khaliqov A, Zamudio C, Perkins MD, Boehme CC, Cobelens F.

PLoS Med. 2011 Nov;8(11):e1001120. doi: 10.1371/journal.pmed.1001120. Epub 2011 Nov 8.

26.

A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

Blakemore R, Nabeta P, Davidow AL, Vadwai V, Tahirli R, Munsamy V, Nicol M, Jones M, Persing DH, Hillemann D, Ruesch-Gerdes S, Leisegang F, Zamudio C, Rodrigues C, Boehme CC, Perkins MD, Alland D.

Am J Respir Crit Care Med. 2011 Nov 1;184(9):1076-84. doi: 10.1164/rccm.201103-0536OC.

27.

Demonstrating the stability of albinterferon alfa-2b in the presence of silicone oil.

Auge KB, Blake-Haskins AW, Devine S, Rizvi S, Li YM, Hesselberg M, Orvisky E, Affleck RP, Spitznagel TM, Perkins MD.

J Pharm Sci. 2011 Dec;100(12):5100-14. doi: 10.1002/jps.22704. Epub 2011 Jul 20.

PMID:
21780119
28.

Feasibility of magnetic bead technology for concentration of mycobacteria in sputum prior to fluorescence microscopy.

Albert H, Ademun PJ, Lukyamuzi G, Nyesiga B, Manabe Y, Joloba M, Wilson S, Perkins MD.

BMC Infect Dis. 2011 May 13;11:125. doi: 10.1186/1471-2334-11-125.

29.

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.

Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens F, Cox H, Alland D, Perkins MD.

Lancet. 2011 Apr 30;377(9776):1495-505. doi: 10.1016/S0140-6736(11)60438-8. Epub 2011 Apr 18.

30.

Diagnostics as essential tools for containing antibacterial resistance.

Okeke IN, Peeling RW, Goossens H, Auckenthaler R, Olmsted SS, de Lavison JF, Zimmer BL, Perkins MD, Nordqvist K.

Drug Resist Updat. 2011 Apr;14(2):95-106. doi: 10.1016/j.drup.2011.02.002. Epub 2011 Mar 12. Review.

PMID:
21398170
31.

Robustness of a loop-mediated isothermal amplification reaction for diagnostic applications.

Francois P, Tangomo M, Hibbs J, Bonetti EJ, Boehme CC, Notomi T, Perkins MD, Schrenzel J.

FEMS Immunol Med Microbiol. 2011 Jun;62(1):41-8. doi: 10.1111/j.1574-695X.2011.00785.x. Epub 2011 Mar 16.

32.

Performance of three LED-based fluorescence microscopy systems for detection of tuberculosis in Uganda.

Albert H, Manabe Y, Lukyamuzi G, Ademun P, Mukkada S, Nyesiga B, Joloba M, Paramasivan CN, Perkins MD.

PLoS One. 2010 Dec 28;5(12):e15206. doi: 10.1371/journal.pone.0015206.

33.

The TDR Tuberculosis Specimen Bank: a resource for diagnostic test developers.

Nathanson CM, Cuevas LE, Cunningham J, Perkins MD, Peeling RW, Guillerm M, Moussy F, Ramsay A.

Int J Tuberc Lung Dis. 2010 Nov;14(11):1461-7.

PMID:
20937188
34.

Rapid molecular detection of tuberculosis and rifampin resistance.

Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD.

N Engl J Med. 2010 Sep 9;363(11):1005-15. doi: 10.1056/NEJMoa0907847. Epub 2010 Sep 1.

35.

Comparative effects of pH and ionic strength on protein-protein interactions, unfolding, and aggregation for IgG1 antibodies.

Sahin E, Grillo AO, Perkins MD, Roberts CJ.

J Pharm Sci. 2010 Dec;99(12):4830-48. doi: 10.1002/jps.22198.

PMID:
20821389
36.

Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings.

Banada PP, Sivasubramani SK, Blakemore R, Boehme C, Perkins MD, Fennelly K, Alland D.

J Clin Microbiol. 2010 Oct;48(10):3551-7. doi: 10.1128/JCM.01053-10. Epub 2010 Aug 18.

37.

Dynamic antibody responses to the Mycobacterium tuberculosis proteome.

Kunnath-Velayudhan S, Salamon H, Wang HY, Davidow AL, Molina DM, Huynh VT, Cirillo DM, Michel G, Talbot EA, Perkins MD, Felgner PL, Liang X, Gennaro ML.

Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14703-8. doi: 10.1073/pnas.1009080107. Epub 2010 Jul 28.

38.

Mitochondrial DNA targets increase sensitivity of malaria detection using loop-mediated isothermal amplification.

Polley SD, Mori Y, Watson J, Perkins MD, González IJ, Notomi T, Chiodini PL, Sutherland CJ.

J Clin Microbiol. 2010 Aug;48(8):2866-71. doi: 10.1128/JCM.00355-10. Epub 2010 Jun 16.

39.

Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice.

Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, Zumla A.

Lancet. 2010 May 29;375(9729):1920-37. doi: 10.1016/S0140-6736(10)60359-5. Epub 2010 May 18. Review.

PMID:
20488517
40.

Evaluation of Diagnos TB AG, a flow-through immunoassay for rapid detection of pulmonary tuberculosis.

Reither K, Saathoff E, Jung J, Minja LT, Machibya H, Maboko L, Perkins MD, Hoelscher M, Boehme CC.

Int J Tuberc Lung Dis. 2010 Feb;14(2):238-40.

PMID:
20074417
41.

Novel and improved technologies for tuberculosis diagnosis: progress and challenges.

Pai M, Minion J, Sohn H, Zwerling A, Perkins MD.

Clin Chest Med. 2009 Dec;30(4):701-16, viii. doi: 10.1016/j.ccm.2009.08.016. Review.

PMID:
19925962
42.

Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology.

Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, Safi H, Blakemore R, Lan NT, Jones-López EC, Levi M, Burday M, Ayakaka I, Mugerwa RD, McMillan B, Winn-Deen E, Christel L, Dailey P, Perkins MD, Persing DH, Alland D.

J Clin Microbiol. 2010 Jan;48(1):229-37. doi: 10.1128/JCM.01463-09. Epub 2009 Oct 28.

43.

Implications of storing urinary DNA from different populations for molecular analyses.

Cannas A, Kalunga G, Green C, Calvo L, Katemangwe P, Reither K, Perkins MD, Maboko L, Hoelscher M, Talbot EA, Mwaba P, Zumla AI, Girardi E, Huggett JF; TB trDNA consortium.

PLoS One. 2009 Sep 10;4(9):e6985. doi: 10.1371/journal.pone.0006985.

44.

Working without a blindfold: the critical role of diagnostics in malaria control.

Perkins MD, Bell DR.

Malar J. 2008 Dec 11;7 Suppl 1:S5. doi: 10.1186/1475-2875-7-S1-S5. Review.

45.

Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countries.

Acuna-Villaorduna C, Vassall A, Henostroza G, Seas C, Guerra H, Vasquez L, Morcillo N, Saravia J, O'Brien R, Perkins MD, Cunningham J, Llanos-Zavalaga L, Gotuzzo E.

Clin Infect Dis. 2008 Aug 15;47(4):487-95. doi: 10.1086/590010.

PMID:
18636955
46.

Making malaria testing relevant: beyond test purchase.

Bell D, Perkins MD.

Trans R Soc Trop Med Hyg. 2008 Nov;102(11):1064-6. doi: 10.1016/j.trstmh.2008.05.007. Epub 2008 Jun 30. Review.

PMID:
18586290
47.

Confronting the scientific obstacles to global control of tuberculosis.

Young DB, Perkins MD, Duncan K, Barry CE 3rd.

J Clin Invest. 2008 Apr;118(4):1255-65. doi: 10.1172/JCI34614. Review.

48.

Facing the crisis: improving the diagnosis of tuberculosis in the HIV era.

Perkins MD, Cunningham J.

J Infect Dis. 2007 Aug 15;196 Suppl 1:S15-27. Review.

PMID:
17624822
49.

Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review.

Mase SR, Ramsay A, Ng V, Henry M, Hopewell PC, Cunningham J, Urbanczik R, Perkins MD, Aziz MA, Pai M.

Int J Tuberc Lung Dis. 2007 May;11(5):485-95. Review.

PMID:
17439669
50.

Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries.

Boehme CC, Nabeta P, Henostroza G, Raqib R, Rahim Z, Gerhardt M, Sanga E, Hoelscher M, Notomi T, Hase T, Perkins MD.

J Clin Microbiol. 2007 Jun;45(6):1936-40. Epub 2007 Mar 28.

Supplemental Content

Loading ...
Support Center